Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.

Sayer GR, McGough JJ, Levitt J, Cowen J, Sturm A, Castelo E, McCracken JT.

J Child Adolesc Psychopharmacol. 2016 Dec;26(10):882-888. Epub 2016 Aug 2.

2.

Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

Sugrue D, Bogner R, Ehret MJ.

Am J Health Syst Pharm. 2014 Jul 15;71(14):1163-70. doi: 10.2146/ajhp130638. Review.

PMID:
24973373
3.

Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder.

Silva RR, Brams M, McCague K, Pestreich L, Muniz R.

Clin Neuropharmacol. 2013 Jul-Aug;36(4):117-21. doi: 10.1097/WNF.0b013e31829aa92c.

PMID:
23860345

Supplemental Content

Loading ...
Support Center